Drug Type Monoclonal antibody |
Synonyms MT 3534, MT3534 |
Target |
Action inhibitors |
Mechanism PAD4 inhibitors(peptidyl arginine deiminase 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Autoimmune Diseases | Phase 1 | Japan | 09 Aug 2024 | |
| Rheumatoid Arthritis | Preclinical | Japan | 01 Jun 2025 |






